Changes in Markers of Disease Progression in HIV-1 Seroconverters
Noya Galai(University of Haifa), Álvaro Muñoz(Universidad de Guadalajara), Neil M.H. Graham(UK Dementia Research Institute), Kan Chen, Joseph B. Margolick(Johns Hopkins University), David Vlahov(Johns Hopkins University)
Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology
January 1, 1995
Cited by 41
Related Papers
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
|New England Journal of Medicine|2016|2k
HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS)
|The Lancet|2002|1.1k
The Natural History of Hepatitis C Virus Infection
|JAMA|2000|1.1k
Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis
|JAMA Dermatology|2019|505